Nordea Investment Management AB Purchases 1,235 Shares of Axon Enterprise, Inc $AXON

Nordea Investment Management AB boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 13.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,338 shares of the biotechnology company’s stock after buying an additional 1,235 shares during the period. Nordea Investment Management AB’s holdings in Axon Enterprise were worth $7,306,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of AXON. Stone House Investment Management LLC bought a new position in shares of Axon Enterprise in the 3rd quarter worth about $29,000. Hemington Wealth Management boosted its position in shares of Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares in the last quarter. Whipplewood Advisors LLC grew its stake in Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the period. Darwin Wealth Management LLC acquired a new stake in Axon Enterprise during the second quarter worth approximately $37,000. Finally, NewSquare Capital LLC increased its holdings in Axon Enterprise by 96.2% in the second quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after purchasing an additional 25 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $636.04 on Friday. The business’s fifty day moving average is $571.18 and its 200 day moving average is $682.87. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The stock has a market cap of $50.19 billion, a P/E ratio of 201.28, a P/E/G ratio of 20.06 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The business had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same quarter in the previous year, the company posted $1.45 EPS. The business’s quarterly revenue was up 30.6% on a year-over-year basis. Sell-side analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,134 shares of Axon Enterprise stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the transaction, the chief accounting officer owned 13,740 shares in the company, valued at approximately $8,244,000. The trade was a 7.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $619.01, for a total value of $6,190,100.00. Following the sale, the chief executive officer directly owned 3,100,997 shares of the company’s stock, valued at $1,919,548,152.97. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 60,540 shares of company stock worth $34,684,738 over the last ninety days. Insiders own 4.40% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of a number of research analyst reports. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price on the stock in a research report on Tuesday, January 6th. UBS Group cut their target price on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Royal Bank Of Canada assumed coverage on shares of Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target for the company. Finally, Cowen reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.